Double network hydrogels make drug-releasing systems safer
Posted: 26 July 2017 | Dr Zara Kassam (European Pharmaceutical Review) | No comments yet
Double network hydrogel composed of two interwoven polymer nets to improve the safety of drug-delivery systems that reside within the stomach…
Researchers have developed a double network hydrogel composed of two interwoven polymer nets, to improve the safety of drug-delivery systems in the stomach.
The network has been designed so that the hydrogel can be triggered to dissolve if the biocompatible agents EDTA (ethylenediaminetetraacetic acid) and GSH (glutathione) are consumed. The combination of EDTA and GSH can quickly break down the cross-links holding the two polymer nets together, allowing the drug to be released within the stomach making it easier for patients to receive their full course of treatment.
“This material represents one of the first examples of a triggerable, tough hydrogel and could thus be used in many different applications such as supporting stem cell growth in the lab or in bariatric medicine,” said Dr Carlo Traverso of the Division of Gastroenterology at Brigham and Women’s Hospital. The next step in their research will be additional pre-clinical studies to further test the safety and stress resistance of the hydrogels before they can be used in people.
“A lot of our work is cantered on the concept of making it easier for patients to take their medications. A triggerable, tough hydrogel allows us to create systems that can easily deliver drugs over long periods of time while simultaneously addressing several of the chief safety concerns of these types of devices,” said Dr Traverso.
Hydrogels are appealing for a number of reasons. They are mainly composed of water so they can shrink in their dry state to become small enough to swallow, and then can expand and swell in the stomach to avoid passing into the small intestine. They can also be loaded with medicine and release it in a controlled manner.
However, the challenge with classic hydrogels is that they are relatively weak. The gastric cavity experiences significant forces associated with contractions of the stomach, so the new hydrogels need to be tough enough to withstand the strain.
“We are really excited about the development of this new family of hydrogels and their potential to permit numerous new medical applications,” says Robert Langer, Professor at the Massachusetts Institute of Technology.
Orally administered drug delivery systems are typically made of tough plastics such as thermoplastics or thermosets, but these materials present safety concerns in that they can cause physical obstructions in the gastrointestinal (GI) tract and are difficult to remove in the case of an allergic reaction. Instead, hydrogels, which are softer and potentially more biocompatible, are an appealing alternative for gastric resident systems, showed a study published in Nature Communications.
Related topics
Related organisations
Alexander von Humboldt Foundation, Bill & Melinda Gates Foundation, Gastroenterology at Brigham and Women's Hospital., National Institutes of Health (NIH)
